Are you Dr. Malinoski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1115 Willow Pond Ln
Leland, NC 28451Phone+1 910-599-7058
Summary
- Dr. Frank Malinoski, MD is a family physician in Leland, North Carolina. He is currently licensed to practice medicine in North Carolina and Maryland.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumInternship, Transitional Year, 1985 - 1986
Albany Medical CollegeClass of 1985
Certifications & Licensure
MD State Medical License 1986 - 2017
NC State Medical License 2011 - 2016
Clinical Trials
- Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants Start of enrollment: 2006 Oct 01
- A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 7 citationsThe nanomedicines alliance: an industry perspective on nanomedicinesFrank J. Malinoski
Nanomedicine. 2014-11-01 - 16 citationsEngineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.Anton Beletskii, Ashley Galloway, Shyam Rele, Michele R. Stone, Frank J. Malinoski
Human Vaccines & Immunotherapeutics. 2014-04-22 - 61 citationsDevelopment of a nanoparticle-based influenza vaccine using the PRINT technology.Ashley Galloway, Andrew Murphy, Joseph M. DeSimone, Jie Di, Jennifer P. Herrmann
Nanomedicine. 2013-05-01
Press Mentions
Eveliqure Announces Initiation of Phase 1 Clinical Study for Shigella and ETEC Vaccine CandidateSeptember 24th, 2020- Eveliqure Announces Regulatory Approval to Commence First Clinical Studies with Its Combined Shigella and ETEC VaccineJune 9th, 2020
Frank Malinoski, MD, PhD, Joins Affinivax as Senior Vice President of Clinical Development and Regulatory AffairsApril 16th, 2019
